Chinese
Japan
English
Your Trusted CDMO Partner Accelerating Biologics, Cell & Gene Therapies, and mRNA Innovations
ProBio, a subsidiary of GenScript, is a global CDMO offering end-to-end services from discovery to GMP for plasmids, antibodies, and cell & gene therapies. We bring together multidisciplinary expertise to accelerate development and manufacturing through customized, and comprehensive services.
ProBio provides end‑to‑end CGT support, covering CMC for plasmids, viral vectors, mRNA vaccines, and nucleic acid drugs, from IND filing through clinical and commercial manufacturing. Our integrated CMC services span cell banking, process development, characterization and validation, analytical development, and stability studies.
We also offer innovative biologics discovery and development capabilities, including antibody discovery, engineering, and in vitro/in vivo pharmacology. ProBio delivers a full DNA‑to‑GMP platform with stable cell line development, host cell licensing, process and analytical development, and clinical to commercial manufacturing.
ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 150 IND approvals since October 2017.
We have established GMP capacity meeting the regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA)
Integrated discovery and early development support to enable smooth transition into IND-enabling studies.
Comprehensive biologics development and manufacturing, including cell line development, upstream and downstream processing, and drug product.
Specialized plasmid DNA development and GMP manufacturing to support cell and gene therapy programs, from early development through clinical and commercial supply. Manufactured at our U.S.-based Hopewell, New Jersey facility, designed to meet FDA regulatory expectations.
End-to-end viral vector development and GMP manufacturing to support clinical and commercial programs.
Integrated mRNA development and manufacturing solutions designed for speed, scalability, and quality.
ProBio operates a growing global network of development and manufacturing facilities to support U.S. and international programs.
Hopewell, New Jersey — A U.S.-based Cell & Gene Therapy Center of Excellence specializing in plasmid DNA and viral vector development and GMP manufacturing. The Hopewell site is designed to meet FDA regulatory expectations and support close collaboration with U.S. clients.
Multiple sites supporting discovery, development, and GMP manufacturing across modalities.
Our global footprint enables proximity to customers, alignment with regional regulatory requirements, and reliable supply across key markets.
cGMP-compliant facilities aligned with global regulatory standards (FDA, EMA, NMPA)
Experience supporting programs from early development through commercial supply
Trusted partner to biotech and biopharma companies worldwide
Dedicated modality-focused teams and purpose-built facilities
To be a leading global CDMO, renowned for cutting-edge technology to enable our customers to deliver life-changing therapies worldwide.
Through our commitment to quality, collaboration, and innovation, ProBio delivers customized solutions to transform scientific discoveries into market-ready therapies, to make a lasting impact on patients’ health and well-being.
ProBio works with companies who are developing advanced therapies. We work with companies of all sizes and from discovery phases through to commercialization. We can offer advice and proven expertise in most areas of advanced therapy manufacturing. Our strengths lie in risk-mitigation for biologics, antibodies, and advanced modalities. At ProBio, our processes minimize variability before clinical risk ever begins.
Of course, and across many modalities! In our core capabilities you find more details on what we can offer, as well as case studies and typical timelines.
Yes! We support commercial manufacturing for a number of advanced therapy modalities and in various global locations. Simply click on core capabilities for more detail, or contact us using the form below.
It’s very simple, follow the guidance below for starting a conversation. Tell us about your molecule or project and our experts will help you identify the right development and manufacturing path.
Tell us about your molecule or project. Our experts will help you identify the right development and manufacturing path.